[HTML][HTML] From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
H Liu, W Shen, W Liu, Z Yang, D Yin, C Xiao - Bioactive Materials, 2024 - Elsevier
Traditional cancer therapy methods, especially those directed against specific intracellular
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy.
H Liu, W Shen, W Liu, Z Yang, D Yin, C Xiao - Bioactive Materials, 2023 - europepmc.org
Traditional cancer therapy methods, especially those directed against specific intracellular
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
[HTML][HTML] From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
H Liu, W Shen, W Liu, Z Yang, D Yin, C Xiao - Bioactive Materials, 2024 - ncbi.nlm.nih.gov
Traditional cancer therapy methods, especially those directed against specific intracellular
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
H Liu, W Shen, W Liu, Z Yang, D Yin… - Bioactive …, 2023 - pubmed.ncbi.nlm.nih.gov
Traditional cancer therapy methods, especially those directed against specific intracellular
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
[PDF][PDF] From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
H Liu, W Shen, W Liu, Z Yang, D Yin, C Xiao - Bioactive Materials, 2024 - researchgate.net
Traditional cancer therapy methods, especially those directed against specific intracellular
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
H Liu, W Shen, W Liu, Z Yang, D Yin, C Xiao - Bioactive Materials, 2024 - agris.fao.org
Traditional cancer therapy methods, especially those directed against specific intracellular
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
[引用][C] From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
H Liu, W Shen, W Liu, Z Yang, D Yin, C Xiao - Bioactive Materials, 2024 - europepmc.org
Traditional cancer therapy methods, especially those directed against specific intracellular
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …